Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs-Reference-Cited by-同舟云学术

Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs

Published:1991-10 Issue:2 Volume:104 Page:294-295
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Vegh Agnes,Szekeres Laszlo,Parratt James R.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1991.tb12424.x/fullpdf

Reference10 articles.

1. Reperfusion-induced arrhythmias: Mechanisms of protection by glucose and mannitol;BERNIER;Am. J. Physiol.,1988

2. Anatagonizing bradykinin (BK) obliterates the cardioprotective effects of bradykinin and angiotensin-converting enzyme (ACE) inhibitors in ischemic hearts;LINZ;Drug Dev. Res.,1990

3. A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism;LOCHNER;Br. J. Pharmacol.,1966

4. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist;MARTORANA;Eur. J. Pharmacol.,1990

5. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium;MURRY;Circulation,1986

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bradykinin-(1–9) mitigates autophagy through upregulating PI3K/Akt in rats with myocardial infarction;Biochemical and Biophysical Research Communications;2023-06

2. Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review;Current Vascular Pharmacology;2022-09

3. The Role of Bradykinin System in Type 2 Diabetes;Journal of Diabetes & Metabolism;2016

4. Genetic Manipulation and Genetic Variation of the Kallikrein-Kinin System: Impact on Cardiovascular and Renal Diseases;Recent Developments in the Regulation of Kinins;2014

5. The kinin system in hypertensive pathophysiology;Inflammopharmacology;2012-04-17